Healthcare IT Today
JANUARY 8, 2024
It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.
Lloyd Price
SEPTEMBER 2, 2023
This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. This trend is expected to continue in 2023, particularly in the areas of primary care, diagnostics, and hospital services.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.
Expert insights. Personalized for you.
81 
Let's personalize your content